References

10.1001/jamaneurol.2014.3049

10.1001/jamaneurol.2014.3049 · ExternalCitation · doi-reference

Nerve growth factor gene therapy activation of neuronal responses in Alzheimer disease

10.1001/jamaneurol.2015.1807 · ExternalCitation · doi-reference

Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease a randomized clinical trial

10.1001/jamaneurol.2018.0233 · ExternalCitation · doi-reference

CSF Abeta42/Abeta40 and Abeta42/Abeta38 ratios: better diagnostic markers of Alzheimer disease

10.1002/acn3.274 · ExternalCitation · doi-reference

Reduction of cortical TrkA but not p75 NTR protein in early-stage Alzheimer’s disease

10.1002/ana.20233 · ExternalCitation · doi-reference

Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

10.1002/ana.21696 · ExternalCitation · doi-reference

Locus‐specific mutation databases for neurodegenerative brain diseases

10.1002/humu.22117 · ExternalCitation · doi-reference

1H MRS in acute traumatic brain injury

10.1002/jmri.1880080412 · ExternalCitation · doi-reference

Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer’s disease

10.1002/jnr.21944 · ExternalCitation · doi-reference

Sendai virus vector‐mediated brain‐derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer’s disease

10.1002/jnr.22830 · ExternalCitation · doi-reference

Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate β-amyloid plaque deposition

10.1006/exnr.1998.6956 · ExternalCitation · doi-reference

TREM2 regulates microglial cell activation in response to demyelination in vivo

10.1007/s00401-015-1388-1 · ExternalCitation · doi-reference

Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study

10.1007/s00429-010-0295-4 · ExternalCitation · doi-reference

Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder

10.1007/s11011-020-00622-2 · ExternalCitation · doi-reference

Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease

10.1007/s11481-016-9721-6 · ExternalCitation · doi-reference

Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer’s disease

10.1007/s11596-013-1136-5 · ExternalCitation · doi-reference

Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer’s Disease

10.1007/s12031-017-0889-x · ExternalCitation · doi-reference

Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease

10.1007/s12031-021-01824-8 · ExternalCitation · doi-reference

Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model

10.1007/s12035-019-01827-y · ExternalCitation · doi-reference

Intravenous Transplantation of Human Umbilical Cord Blood Mononuclear Cells Overexpressing Nerve Growth Factor Improves Spatial Memory in APP/PS1 Transgenic Mice with a Model of Alzheimer’s Disease

10.1007/s12668-017-0497-9 · ExternalCitation · doi-reference

“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician

10.1016/0022-3956(75)90026-6 · ExternalCitation · doi-reference

Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons

10.1016/0169-328x(86)90020-3 · ExternalCitation · doi-reference

p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF

10.1016/0896-6273(92)90184-f · ExternalCitation · doi-reference

Cholinergic neurodegeneration in Alzheimer disease mouse models

10.1016/b978-0-12-819973-2.00013-7 · ExternalCitation · doi-reference

Circadian changes in Alzheimer’s disease: neurobiology, clinical problems, and therapeutic opportunities

10.1016/b978-0-12-819975-6.00018-2 · ExternalCitation · doi-reference

Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer׳s disease

10.1016/j.apsb.2018.12.010 · ExternalCitation · doi-reference

Synaptic basis of Alzheimer’s disease: focus on synaptic amyloid beta, P-tau and mitochondria

10.1016/j.arr.2020.101208 · ExternalCitation · doi-reference

Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer’s disease

10.1016/j.bbi.2010.05.010 · ExternalCitation · doi-reference

Aged Tg2576 mice are impaired on social memory and open field habituation tests

10.1016/j.bbr.2008.09.042 · ExternalCitation · doi-reference

Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer’s disease as well as in wild-type mice

10.1016/j.bbr.2015.05.002 · ExternalCitation · doi-reference

Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer’s disease

10.1016/j.bbr.2017.09.009 · ExternalCitation · doi-reference

Genetic cathepsin B deficiency reduces β-amyloid in transgenic mice expressing human wild-type amyloid precursor protein

10.1016/j.bbrc.2009.05.131 · ExternalCitation · doi-reference

Precise gene delivery systems with detachable albumin shell remodeling dysfunctional microglia by TREM2 for treatment of Alzheimer’s disease

10.1016/j.biomaterials.2021.121360 · ExternalCitation · doi-reference

Gene therapy clinical trials, where do we go? An overview

10.1016/j.biopha.2022.113324 · ExternalCitation · doi-reference

Myelin changes at the early stage of 5XFAD mice

10.1016/j.brainresbull.2017.12.013 · ExternalCitation · doi-reference

Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer’s disease

10.1016/j.brainresbull.2019.06.015 · ExternalCitation · doi-reference

Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective

10.1016/j.cell.2005.02.008 · ExternalCitation · doi-reference

TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model

10.1016/j.cell.2015.01.049 · ExternalCitation · doi-reference

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease

10.1016/j.cell.2017.07.023 · ExternalCitation · doi-reference

Alzheimer Disease: an Update on Pathobiology and Treatment Strategies

10.1016/j.cell.2019.09.001 · ExternalCitation · doi-reference

Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

10.1016/j.cell.2022.05.017 · ExternalCitation · doi-reference

APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release

10.1016/j.celrep.2023.113252 · ExternalCitation · doi-reference

Anti-epileptogenic effects of synaptic vesicle protein 2A modulation in a mouse model of Alzheimer’s disease

10.1016/j.eplepsyres.2022.106994 · ExternalCitation · doi-reference

Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons

10.1016/j.expneurol.2008.03.004 · ExternalCitation · doi-reference

Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery

10.1016/j.expneurol.2008.10.004 · ExternalCitation · doi-reference

Molecular imaging of neurodegeneration by a novel cross-disease biomarker

10.1016/j.expneurol.2009.05.032 · ExternalCitation · doi-reference

Modeling the complex pathology of Alzheimer’s disease in Drosophila

10.1016/j.expneurol.2015.05.013 · ExternalCitation · doi-reference

Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer’s disease

10.1016/j.gene.2016.04.032 · ExternalCitation · doi-reference

Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer’s disease pathology in transgenic mouse model

10.1016/j.ijbiomac.2022.03.203 · ExternalCitation · doi-reference

Alterations in cholinergic and non‐cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β‐amyloid plaque pathology

10.1016/j.ijdevneu.2003.08.001 · ExternalCitation · doi-reference

A phase1 study of stereotactic gene delivery of AAV2‐NGF for Alzheimer’s disease

10.1016/j.jalz.2013.09.004 · ExternalCitation · doi-reference

Neuronal neprilysin overexpression is associated with attenuation of Aβ-related spatial memory deficit

10.1016/j.nbd.2006.08.003 · ExternalCitation · doi-reference

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model

10.1016/j.nbd.2008.10.006 · ExternalCitation · doi-reference

Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice

10.1016/j.nbd.2010.10.002 · ExternalCitation · doi-reference

Autophagy failure in Alzheimer’s disease-locating the primary defect

10.1016/j.nbd.2011.01.021 · ExternalCitation · doi-reference

APOE4 confers transcriptomic and functional alterations to primary mouse microglia

10.1016/j.nbd.2022.105615 · ExternalCitation · doi-reference

Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology

10.1016/j.neubiorev.2020.02.012 · ExternalCitation · doi-reference

A metabolomic study of the CRND8 transgenic mouse model of Alzheimer’s disease

10.1016/j.neuint.2010.04.001 · ExternalCitation · doi-reference

Exploratory activity and spatial learning in 12-month-old APP695SWE/co+PS1/ΔE9mice with amyloid plaques

10.1016/j.neulet.2005.08.028 · ExternalCitation · doi-reference

The role of APOE in transgenic mouse models of AD

10.1016/j.neulet.2019.134285 · ExternalCitation · doi-reference

APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1

10.1016/j.neurobiolaging.2003.09.008 · ExternalCitation · doi-reference

Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer’s disease: review and hypothesis

10.1016/j.neurobiolaging.2005.01.004 · ExternalCitation · doi-reference

Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging

10.1016/j.neurobiolaging.2007.09.003 · ExternalCitation · doi-reference

Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis

10.1016/j.neurobiolaging.2008.08.005 · ExternalCitation · doi-reference

Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy

10.1016/j.neurobiolaging.2009.04.006 · ExternalCitation · doi-reference

The genetic architecture of Alzheimer’s disease: beyond APP, PSENS and APOE

10.1016/j.neurobiolaging.2010.03.025 · ExternalCitation · doi-reference

Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer’s disease

10.1016/j.neurobiolaging.2010.05.027 · ExternalCitation · doi-reference

Age-related decline in white matter integrity in a mouse model of tauopathy: an invivo diffusion tensor magnetic resonance imaging study

10.1016/j.neurobiolaging.2013.12.009 · ExternalCitation · doi-reference

Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia

10.1016/j.neurobiolaging.2013.12.023 · ExternalCitation · doi-reference

Increased Alzheimer’s disease-like pathology in the APP/ PS1δE9mouse model lacking Nrf2 through modulation of autophagy

10.1016/j.neurobiolaging.2014.09.004 · ExternalCitation · doi-reference

Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains

10.1016/j.neurobiolaging.2015.05.010 · ExternalCitation · doi-reference

Intracerebral adeno-associated virus gene delivery of apolipoproteinE2markedly reduces brain amyloid pathology in Alzheimer’s disease mouse models

10.1016/j.neurobiolaging.2016.04.020 · ExternalCitation · doi-reference

Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer’s disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling

10.1016/j.neurobiolaging.2017.03.002 · ExternalCitation · doi-reference

Lentiviral vector–mediated overexpression of Klotho in the brain improves Alzheimer’s disease–like pathology and cognitive deficits in mice

10.1016/j.neurobiolaging.2019.02.003 · ExternalCitation · doi-reference

Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age

10.1016/j.neurobiolaging.2021.12.009 · ExternalCitation · doi-reference

Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice

10.1016/j.neuron.2005.01.040 · ExternalCitation · doi-reference

Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: implications for Alzheimer’s Disease

10.1016/j.neuron.2006.07.027 · ExternalCitation · doi-reference

Probing the Biology of Alzheimer’s Disease in Mice

10.1016/j.neuron.2010.04.031 · ExternalCitation · doi-reference

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal control

10.1016/j.neuron.2013.07.037 · ExternalCitation · doi-reference

Pathological tau disrupts ongoing network activity

10.1016/j.neuron.2015.01.025 · ExternalCitation · doi-reference

Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model

10.1016/j.neuron.2016.09.022 · ExternalCitation · doi-reference

Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer’s Disease

10.1016/j.neuron.2018.02.029 · ExternalCitation · doi-reference

Harnessing Genetic Complexity to Enhance Translatability of Alzheimer’s Disease Mouse Models: a Path toward Precision Medicine

10.1016/j.neuron.2018.11.040 · ExternalCitation · doi-reference

TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge

10.1016/j.neuron.2019.12.007 · ExternalCitation · doi-reference

Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist

10.1016/j.neuron.2023.10.023 · ExternalCitation · doi-reference

Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice

10.1016/j.neuroscience.2003.10.011 · ExternalCitation · doi-reference

Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmission

10.1016/j.neuroscience.2004.11.018 · ExternalCitation · doi-reference

F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice

10.1016/j.neuroscience.2012.07.038 · ExternalCitation · doi-reference

APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: a MRS and MRI study

10.1016/j.nicl.2017.06.009 · ExternalCitation · doi-reference

Expression of Neprilysin in Skeletal Muscle by Ultrasound-Mediated Gene Transfer (Sonoporation) Reduces Amyloid Burden for AD

10.1016/j.omtm.2019.12.012 · ExternalCitation · doi-reference

miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

10.1016/j.omtn.2020.01.010 · ExternalCitation · doi-reference

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

10.1016/j.pneurobio.2006.12.003 · ExternalCitation · doi-reference

Alterations in immunological and neurological gene expression patterns in Alzheimer’s disease tissues

10.1016/j.yexcr.2006.10.028 · ExternalCitation · doi-reference

The effects of rAAV2-mediated NGF gene delivery in adult and aged rats

10.1016/j.ymthe.2003.11.010 · ExternalCitation · doi-reference

Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss

10.1016/s0002-9440(10)64544-0 · ExternalCitation · doi-reference

NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats

10.1016/s0006-8993(00)02634-2 · ExternalCitation · doi-reference

Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein

10.1016/s0006-8993(02)03262-6 · ExternalCitation · doi-reference

Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer’s disease

10.1016/s0166-4328(99)00037-6 · ExternalCitation · doi-reference

APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress

10.1016/s0197-4580(02)00016-7 · ExternalCitation · doi-reference

Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form

10.1016/s0304-3940(03)00898-x · ExternalCitation · doi-reference

Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system

10.1016/s0306-4522(96)00613-6 · ExternalCitation · doi-reference

Triple-transgenic model of Alzheimer’s Disease with plaques and tangles: intracellular Aβ and synaptic dysfunction

10.1016/s0896-6273(03)00434-3 · ExternalCitation · doi-reference

Alzheimer’s disease: clinical trials and drug development

10.1016/s1474-4422(10)70119-8 · ExternalCitation · doi-reference

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

10.1038/329065a0 · ExternalCitation · doi-reference

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease

10.1038/35050110 · ExternalCitation · doi-reference

AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice

10.1038/gt.2011.126 · ExternalCitation · doi-reference

Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice

10.1038/gt.2013.85 · ExternalCitation · doi-reference

Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Aβ deposits in APP + PS1 transgenic mice

10.1038/mt.2008.148 · ExternalCitation · doi-reference

AΒ-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer’s disease mice

10.1038/mt.2010.111 · ExternalCitation · doi-reference

AAV2/1 CD74 gene transfer reduces β-amyloidosis and improves learning and memory in a mouse model of Alzheimer’s disease

10.1038/mt.2015.142 · ExternalCitation · doi-reference

ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

10.1038/nature24016 · ExternalCitation · doi-reference

Alzheimer’s Disease Neuroimaging I. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

10.1038/ncomms13249 · ExternalCitation · doi-reference

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

10.1038/nm1239 · ExternalCitation · doi-reference

Single App knock-in mouse models of Alzheimer’s disease

10.1038/nn.3697 · ExternalCitation · doi-reference

Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer’s disease

10.1038/npp.2009.197 · ExternalCitation · doi-reference

Animal models of Alzheimer’s disease and frontotemporal dementia

10.1038/nrn2420 · ExternalCitation · doi-reference

Apolipoprotein e and Alzheimer disease: risk, mechanisms and therapy

10.1038/nrneurol.2012.263 · ExternalCitation · doi-reference

APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease

10.1038/s41380-021-01076-3 · ExternalCitation · doi-reference

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases

10.1038/s41392-021-00779-x · ExternalCitation · doi-reference

REM sleep promotes experience-dependent dendritic spine elimination in the mouse cortex

10.1038/s41467-020-18592-5 · ExternalCitation · doi-reference

Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice

10.1038/s41551-021-00759-0 · ExternalCitation · doi-reference

AAV-based in vivo gene therapy for neurological disorders

10.1038/s41573-023-00766-7 · ExternalCitation · doi-reference

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

10.1038/s41582-019-0228-7 · ExternalCitation · doi-reference

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

10.1038/s41582-020-00435-y · ExternalCitation · doi-reference

Rodent models for Alzheimer disease

10.1038/s41583-018-0054-8 · ExternalCitation · doi-reference

Advances in epigenetics link genetics to the environment and disease

10.1038/s41586-019-1411-0 · ExternalCitation · doi-reference

APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes

10.1038/s41586-022-05439-w · ExternalCitation · doi-reference

High-dose AAV gene therapy deaths

10.1038/s41587-020-0642-9 · ExternalCitation · doi-reference

New insights into the genetic etiology of Alzheimer’s disease and related dementias

10.1038/s41588-022-01024-z · ExternalCitation · doi-reference

Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease

10.1038/s41593-018-0101-9 · ExternalCitation · doi-reference

Alzheimer’s-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia

10.1038/s41593-020-0650-6 · ExternalCitation · doi-reference

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease

10.1038/s41597-021-01054-y · ExternalCitation · doi-reference

APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β

10.1038/s43587-021-00073-z · ExternalCitation · doi-reference

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

10.1038/s43587-023-00368-3 · ExternalCitation · doi-reference

Transport pathways for clearance of human Alzheimer’s amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system

10.1038/sj.jcbfm.9600419 · ExternalCitation · doi-reference

Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin

10.1042/bj3270023 · ExternalCitation · doi-reference

Current and Future Treatments in Alzheimer’s Disease

10.1055/s-0039-1678581 · ExternalCitation · doi-reference

Dementia, and Cortical Deposition of β-Amyloid Protein

10.1056/nejm199511093331902 · ExternalCitation · doi-reference

Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke

10.1056/nejmc2215148 · ExternalCitation · doi-reference

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

10.1073/pnas.0230450100 · ExternalCitation · doi-reference

Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer’s disease

10.1073/pnas.0409072102 · ExternalCitation · doi-reference

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease

10.1073/pnas.0600948103 · ExternalCitation · doi-reference

Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer’s disease

10.1073/pnas.0908397106 · ExternalCitation · doi-reference

Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo

10.1073/pnas.1031520100 · ExternalCitation · doi-reference

Proteopathic tau seeding predicts tauopathy in vivo

10.1073/pnas.1411649111 · ExternalCitation · doi-reference

Phospholipid dysregulation contributes to apoe4-associated cognitive deficits in Alzheimer’s disease pathogenesis

10.1073/pnas.1510011112 · ExternalCitation · doi-reference

TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy

10.1073/pnas.1710311114 · ExternalCitation · doi-reference

Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy

10.1073/pnas.96.19.10893 · ExternalCitation · doi-reference

Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation

10.1073/pnas.98.4.1941 · ExternalCitation · doi-reference

Hydrolysis of peptide hormones by endothelin-converting enzyme-1: a comparison with neprilysin

10.1074/jbc.274.7.4053 · ExternalCitation · doi-reference

Alzheimer’s disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

10.1074/jbc.c200642200 · ExternalCitation · doi-reference

Degradation of the Alzheimer’s Amyloid β Peptide by Endothelin-converting Enzyme

10.1074/jbc.m007579200 · ExternalCitation · doi-reference

Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695

10.1074/jbc.m100710200 · ExternalCitation · doi-reference

APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response

10.1074/jbc.m306923200 · ExternalCitation · doi-reference

Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice

10.1074/jbc.m409876200 · ExternalCitation · doi-reference

Inhibitors of Cathepsin B Improve Memory and Reduce β-Amyloid in Transgenic Alzheimer Disease Mice Expressing the Wild-type, but Not the Swedish Mutant, β-Secretase Site of the Amyloid Precursor Protein

10.1074/jbc.m708362200 · ExternalCitation · doi-reference

Amyloid precursor protein trafficking, processing, and function

10.1074/jbc.r800019200 · ExternalCitation · doi-reference

Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation

10.1074/jbc.ra119.009487 · ExternalCitation · doi-reference

Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for Alzheimer’s disease identifies a need for improved vector delivery

10.1089/hum.2019.367 · ExternalCitation · doi-reference

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer’s disease

10.1093/aje/kwi202 · ExternalCitation · doi-reference

Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer’s disease pathology in aged squirrel monkeys

10.1093/brain/awab129 · ExternalCitation · doi-reference

Amyloid-β-activated microglia can induce compound proteinopathies

10.1093/brain/awae221 · ExternalCitation · doi-reference

Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer’s disease mice

10.1093/brain/awx272 · ExternalCitation · doi-reference

Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis

10.1093/braincomms/fcac286 · ExternalCitation · doi-reference

DNA methylation alterations in Alzheimer’s disease

10.1093/eep/dvx008 · ExternalCitation · doi-reference

Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation

10.1093/hmg/ddt451 · ExternalCitation · doi-reference

Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses

10.1093/jnen/59.9.751 · ExternalCitation · doi-reference

Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study

10.1093/jnen/64.2.113 · ExternalCitation · doi-reference

Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer’s disease mouse model

10.1096/fj.201700064r · ExternalCitation · doi-reference

Autophagy and neuronal cell death in neurological disorders

10.1101/cshperspect.a008839 · ExternalCitation · doi-reference

Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer’s disease

10.1101/lm.053588.122 · ExternalCitation · doi-reference

Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice

10.1111/acel.12873 · ExternalCitation · doi-reference

Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer’s disease

10.1111/ejn.13442 · ExternalCitation · doi-reference

A mouse model of Alzheimer’s disease displays increased susceptibility to kindling and seizure-associated death

10.1111/epi.12993 · ExternalCitation · doi-reference

Gene therapy in Alzheimer’s disease - potential for disease modification

10.1111/j.1582-4934.2010.01038.x · ExternalCitation · doi-reference

Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer’s disease

10.1111/j.1601-183x.2005.00124.x · ExternalCitation · doi-reference

Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer’s disease-like pathologies in APP/PS1 transgenic mice

10.1111/jnc.13616 · ExternalCitation · doi-reference

Epigenetics and DNA methylomic profiling in Alzheimer’s disease and other neurodegenerative diseases

10.1111/jnc.14148 · ExternalCitation · doi-reference

An isogenic panel of App knock-in mouse models: profiling β-secretase inhibition and endosomal abnormalities

10.1126/sciadv.abm6155 · ExternalCitation · doi-reference

A portrait of Alzheimer secretases - New features and familiar faces

10.1126/science.1064638 · ExternalCitation · doi-reference

Medicine: tau suppression in a neurodegenerative mouse model improves memory function

10.1126/science.1113694 · ExternalCitation · doi-reference

Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice

10.1126/science.274.5284.99 · ExternalCitation · doi-reference

Grafting genetically modified cells to the damaged brain: restorative effects of ngf expression

10.1126/science.3201248 · ExternalCitation · doi-reference

Alzheimer’s Disease and Senile Dementia: loss of Neurons in the Basal Forebrain

10.1126/science.7058341 · ExternalCitation · doi-reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families

10.1126/science.8346443 · ExternalCitation · doi-reference

Role of Nrf2 in Oxidative Stress and Toxicity

10.1146/annurev-pharmtox-011112-140320 · ExternalCitation · doi-reference

Apolipoprotein E alleles as risk factors in Alzheimer’s disease

10.1146/annurev.med.47.1.387 · ExternalCitation · doi-reference

In vivo NMR Studies of the Glutamate Neurotransmitter Flux and Neuroenergetics: implications for Brain Function

10.1146/annurev.physiol.65.092101.142131 · ExternalCitation · doi-reference

Presenilins: members of the γ-Secretase Quartets, But Part-Time Soloists Too

10.1152/physiol.00009.2008 · ExternalCitation · doi-reference

N-Acetyl Aspartate: a Marker for Neuronal Loss or Mitochondrial Dysfunction

10.1159/000017321 · ExternalCitation · doi-reference

Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity

10.1159/000156475 · ExternalCitation · doi-reference

Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice

10.1159/000354777 · ExternalCitation · doi-reference

Apolipoprotein E polymorphism and atherosclerosis

10.1161/01.atv.8.1.1 · ExternalCitation · doi-reference

apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain

10.1172/jci36663 · ExternalCitation · doi-reference

Apo E structure determines VLDL clearance and atherosclerosis risk in mice

10.1172/jci6172 · ExternalCitation · doi-reference

TREM2 sustains microglial expansion during aging and response to demyelination

10.1172/jci77983 · ExternalCitation · doi-reference

A new rating scale for Alzheimer’s disease

10.1176/ajp.141.11.1356 · ExternalCitation · doi-reference

Genetics of Alzheimer disease

10.1177/0891988710383571 · ExternalCitation · doi-reference

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition

10.1186/1742-2094-11-111 · ExternalCitation · doi-reference

Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level

10.1186/1750-1326-10-1 · ExternalCitation · doi-reference

ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice

10.1186/1750-1326-8-16 · ExternalCitation · doi-reference

Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis

10.1186/s12868-018-0446-8 · ExternalCitation · doi-reference

Alzheimer’s disease: risk factors and potentially protective measures

10.1186/s12929-019-0524-y · ExternalCitation · doi-reference

The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease

10.1186/s12974-020-01749-w · ExternalCitation · doi-reference

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cells

10.1186/s12974-023-03003-5 · ExternalCitation · doi-reference

Practical considerations for choosing a mouse model of Alzheimer’s disease

10.1186/s13024-017-0231-7 · ExternalCitation · doi-reference

Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model

10.1186/s13024-019-0337-1 · ExternalCitation · doi-reference

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice

10.1186/s13024-020-00394-4 · ExternalCitation · doi-reference

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

10.1186/s13024-022-00547-7 · ExternalCitation · doi-reference

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

10.1186/s13024-022-00574-4 · ExternalCitation · doi-reference

Sex specific molecular networks and key drivers of Alzheimer’s disease

10.1186/s13024-023-00624-5 · ExternalCitation · doi-reference

Updates on mouse models of Alzheimer’s disease

10.1186/s13024-024-00712-0 · ExternalCitation · doi-reference

Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer’s disease

10.1186/s13041-018-0348-9 · ExternalCitation · doi-reference

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

10.1186/s13195-021-00813-8 · ExternalCitation · doi-reference

A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice

10.1186/s13195-022-01144-y · ExternalCitation · doi-reference

EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease

10.1194/jlr.r076315 · ExternalCitation · doi-reference

Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS

10.1194/jlr.r800069-jlr200 · ExternalCitation · doi-reference

Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice

10.1210/en.2007-1346 · ExternalCitation · doi-reference

Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus–seropositive individuals

10.1212/wnl.43.3_part_1.509 · ExternalCitation · doi-reference

Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: a Novel Therapeutic Approach to Alzheimer Disease

10.1371/journal.pmed.0040262 · ExternalCitation · doi-reference

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases

10.1371/journal.pmed.1002270 · ExternalCitation · doi-reference

Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice

10.1371/journal.pone.0012974 · ExternalCitation · doi-reference

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating

10.1371/journal.pone.0021050 · ExternalCitation · doi-reference

Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels

10.1371/journal.pone.0058752 · ExternalCitation · doi-reference

Early Structural and Functional Defects in Synapses and Myelinated Axons in Stratum Lacunosum Moleculare in Two Preclinical Models for Tauopathy

10.1371/journal.pone.0087605 · ExternalCitation · doi-reference

Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer’s Disease: from Early to Advanced Pathological Stages

10.1371/journal.pone.0130177 · ExternalCitation · doi-reference

Increase in Tau Pathology in P290S Mapt Knock-In Mice Crossed with App NL-G-F Mice

10.1523/eneuro.0247-22.2022 · ExternalCitation · doi-reference

Reducing human Apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice

10.1523/jneurosci.0033-12.2012 · ExternalCitation · doi-reference

Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey

10.1523/jneurosci.10-12-03801.1990 · ExternalCitation · doi-reference

Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer’s disease

10.1523/jneurosci.1146-08.2008 · ExternalCitation · doi-reference

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer’s Disease Mutations: potential Factors in Amyloid Plaque Formation

10.1523/jneurosci.1202-06.2006 · ExternalCitation · doi-reference

Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration

10.1523/jneurosci.15-04-02819.1995 · ExternalCitation · doi-reference

Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport

10.1523/jneurosci.17-07-02295.1997 · ExternalCitation · doi-reference

Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

10.1523/jneurosci.3279-05.2005 · ExternalCitation · doi-reference

ApolipoproteinE4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice

10.1523/jneurosci.4040-10.2010 · ExternalCitation · doi-reference

Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer’s disease

10.1523/jneurosci.4220-08.2009 · ExternalCitation · doi-reference

Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-β Peptide in Mouse Brain

10.1523/jneurosci.4792-03.2004 · ExternalCitation · doi-reference

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice

10.1523/jneurosci.4922-11.2012 · ExternalCitation · doi-reference

Upper airway dysfunction of tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei

10.1523/jneurosci.5261-09.2010 · ExternalCitation · doi-reference

Memory recovery through gene therapy with a single chain antibody fragment selective for Aβ oligomers in a model of Alzheimer’s disease in rats

10.17981/jacn.4.1.2023.2 · ExternalCitation · doi-reference

Uncovering gamma-secretase

10.2174/1567205043332081 · ExternalCitation · doi-reference

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease

10.2183/pjab.89.321 · ExternalCitation · doi-reference

Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy

10.2353/ajpath.2006.050840 · ExternalCitation · doi-reference

Neprilysin: an enzyme candidate to slow the progression of Alzheimer’s disease

10.2353/ajpath.2008.070620 · ExternalCitation · doi-reference

Intracranial injection of PEG-PEI/ROCK II-siRNA improves cognitive impairment in a mouse model of Alzheimer’s disease

10.3109/00207454.2013.877014 · ExternalCitation · doi-reference

Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer’s disease

10.3233/jad-143120 · ExternalCitation · doi-reference

A TgCRND8 Mouse Model of Alzheimer’s Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve

10.3233/jad-150587 · ExternalCitation · doi-reference

Netrin-1 Interrupts Amyloid-beta Amplification, Increases sAbetaPPalpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease

10.3233/jad-151046 · ExternalCitation · doi-reference

Differences in Synaptic Dysfunction between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease

10.3233/jad-170457 · ExternalCitation · doi-reference

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia

10.3233/jad-170702 · ExternalCitation · doi-reference

Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer’s Disease

10.3233/jad-190150 · ExternalCitation · doi-reference

Alzheimer’s disease and down syndrome rodent models exhibit audiogenic seizures

10.3233/jad-2010-100087 · ExternalCitation · doi-reference

DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis

10.32607/actanaturae.11043 · ExternalCitation · doi-reference

Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer’s disease

10.3389/fnagi.2013.00098 · ExternalCitation · doi-reference

Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: a MODEL-AD Study

10.3389/fnagi.2021.713726 · ExternalCitation · doi-reference

Ultrasound Combined With Microbubbles Loading BDNF Retrovirus to Open BloodBrain Barrier for Treatment of Alzheimer’s Disease

10.3389/fphar.2021.615104 · ExternalCitation · doi-reference

Non-Coding RNAs as Sensors of Oxidative Stress in Neurodegenerative Diseases

10.3390/antiox9111095 · ExternalCitation · doi-reference

Modeling Alzheimer’s Disease in Caenorhabditis elegans

10.3390/biomedicines10020288 · ExternalCitation · doi-reference

Age-dependent hippocampal proteomics in the app/ps1 Alzheimer mouse model: a comparative analysis with classical swath/dia and directdia approaches

10.3390/cells10071588 · ExternalCitation · doi-reference

Histone Modifications in Alzheimer’s Disease

10.3390/genes14020347 · ExternalCitation · doi-reference

The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer’s Disease Pathogenesis

10.3390/ijms23158497 · ExternalCitation · doi-reference

Glia-Neurotrophic Factor Relationships: possible Role in Pathobiology of Neuroinflammation-Related Brain Disorders

10.3390/ijms24076321 · ExternalCitation · doi-reference

The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases

10.3390/ijms24119686 · ExternalCitation · doi-reference

TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis

10.4049/jimmunol.1102836 · ExternalCitation · doi-reference

Cutting edge: TREM-2 attenuates macrophage activation

10.4049/jimmunol.177.6.3520 · ExternalCitation · doi-reference

Reduction of glucose metabolism in olfactory bulb is an earlier Alzheimer’s disease-related biomarker in 5XFAD mice

10.4103/0366-6999.162507 · ExternalCitation · doi-reference

Viral and nonviral delivery systems for gene delivery

10.4103/2277-9175.98152 · ExternalCitation · doi-reference

Molecular Differences and Similarities between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis

10.4137/bci.s13025 · ExternalCitation · doi-reference

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

10.7150/ijbs.57078 · ExternalCitation · doi-reference

STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer’s disease animal model

10.7150/thno.56541 · ExternalCitation · doi-reference